FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

371958001: Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197251010 Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1210548014 Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Is a Product containing brompheniramine (medicinal product) false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Is a Codeine-containing product in oral dose form false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Is a Product containing brompheniramine maleate false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Brompheniramine (substance) false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Morphinan opioid false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine (substance) false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Is a Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Central nervous system agent (substance) false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine phosphate false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenylpropanolamine hydrochloride false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Brompheniramine maleate false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Has manufactured dose form Conventional release oral syrup (dose form) false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Is a Brompheniramine-containing product in oral dose form false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Is a Phenylpropanolamine-containing product in oral dose form false Inferred relationship Some
    Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start